The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction : Ameliorative Effect of Solifenacin Succinate (Vesicare^【○!R】), a Bladder-Selective Antimuscarinic Agent, on Overactive Bladder Symptoms, Especially Urgency Episodes

• OHTAKE Akiyoshi

  Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.

• SATO Shuichi

  Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.

• SASAMATA Masao

  Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.

• MIYATA Keiji

  Applied Pharmacology Research Laboratories, Drug Discovery Research, Astellas Pharma Inc.

収録刊行物

• Journal of pharmacological sciences

  Journal of pharmacological sciences 112 (2), 135-141, 2010-02-20

キーワード

• solifenacin
• muscarinic receptor
• overactive bladder
• urgency
• afferent nerve
• lower urinary tract

詳細情報

• CRID: 1571135650013719808
• NII論文ID: 10029888575
• NII書誌ID: AA11806667
• ISSN: 13478613
• 本文言語コード: en
• データソース種別:
  • CiNii Articles